Literature DB >> 1530776

Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A.

J A Howe1, S T Bayley.   

Abstract

We have examined the ability of Ad5 E1A 12S viruses with deletions in E1A exon 1 to induce quiescent baby rat kidney cells to progress through the cell cycle and to undergo mitosis. Measurements of mitotic index and analyses by fluorescence activated cell sorting were correlated with the abilities of the mutant E1A proteins to bind to cellular proteins. All the mutants induced cells to leave G0/G1 and enter S phase, but two groups were defective at inducing mitosis, and cells infected with them appeared to be blocked between the S and M phases. The first group of mutants, with deletions in the regions of residues 4-25 and 30-60, bound p300 poorly or not at all and gave reduced numbers of mitoses. The second group, with deletions between residues 111 and 138 in CR2, failed to bind pRb and were completely defective at inducing mitosis. In this group, mutants lacking residues between 124 and 138 bound p107 and cyclin A at much reduced levels and induced cells to overreplicate their DNA. The site in E1A required to bind cyclin A extends from residue 124 to at least 127. Cyclin A binds to a 107-kDa cellular protein, which by peptide analysis appears identical to p107.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530776     DOI: 10.1016/0042-6822(92)90057-v

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  35 in total

1.  Regulation of the 26S proteasome by adenovirus E1A.

Authors:  A S Turnell; R J Grand; C Gorbea; X Zhang; W Wang; J S Mymryk; P H Gallimore
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

2.  Induction of AP-1 DNA-binding activity and c-fos mRNA by the adenovirus 243R E1A protein and cyclic AMP requires domains necessary for transformation.

Authors:  R W Gedrich; S T Bayley; D A Engel
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

3.  Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein.

Authors:  J S Mymryk; R W Lee; S T Bayley
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

4.  Adenovirus E1A oncogene induces rereplication of cellular DNA and alters DNA replication dynamics.

Authors:  Ghata Singhal; Elisabetta Leo; Saayi Krushna Gadham Setty; Yves Pommier; Bayar Thimmapaya
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

5.  p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen.

Authors:  N L Lill; M J Tevethia; R Eckner; D M Livingston; N Modjtahedi
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Role of p300-family proteins in E1A oncogene induction of cytolytic susceptibility and tumor cell rejection.

Authors:  J L Cook; C K Krantz; B A Routes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

7.  Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300.

Authors:  M O Hottiger; L K Felzien; G J Nabel
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

8.  Complementary functions of E1a conserved region 1 cooperate with conserved region 3 to activate adenovirus serotype 5 early promoters.

Authors:  H K Wong; E B Ziff
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Induction of gene expression by exon 2 of the major E1A proteins of adenovirus type 5.

Authors:  J S Mymryk; S T Bayley
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  The adenovirus E1A 12S product displays functional redundancy in activating the human proliferating cell nuclear antigen promoter.

Authors:  C Kannabiran; G F Morris; C Labrie; M B Mathews
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.